Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users - Global Industry Insights, Trends, Outlook and Oppo

1. Cervical Dysplasia Diagnostic Market - by Diagnostic, and Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users - Global Industry Insights, Trends, Outlook and End Users - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2018-2026 Opportunity Analysis 2018-2026 Cervical dysplasia Cervical dysplasia is a precancerous condition characterized by abnormal growth of endocervical canal cells. Cervical dysplasia is also called as cervical intraepithelial neoplasia. It is a Sexually Transmitted Disease (STD) caused due to human papillomavirus (HPV) infection. Cervical dysplasia can be of two types based on the type of cells it affect - squamous intraepithelial lesion and glandular cell lesions. It occurs in all age groups and it is common in women with 30 years age. Cervical dysplasia can be detected by Pap test, endocervical curettage, and loop electrosurgical excision procedure (LEEP) or HPV DNA test. The cervical dysplasia diagnostic market is expected to witness significant growth over the forecast period, owing to increasing prevalence of disease and increasing awareness regarding utilization of detection test through government screening programmes for regular screening for human papillomavirus. Moreover, high accuracy of HPV test at low cost is expected to fuel growth of the HPV test segment in cervical dysplasia diagnostic market. Request Sample Copy of Research Report @ Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1486 https://www.coherentmarketinsights.com/insight/request-sample/1486 Market Driver: Market Driver: Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV test. However, current practices for cervical dysplasia diagnostic through colposcopy requires trained professional to perform the test, which is major challenge for growth of the market. To overcome this, research institutes and universities are involved in development of innovative diagnosis devices, which in driving growth of the cervical dysplasia diagnostic market. For instance, in July 2017, Duke University in North Carolina developed a pocket

2. colposcopy device enable with laptop and mobile connection. The device was funded by National Institutes of Health (NIH). The untreated cervical dysplasia progresses into cervical cancer or cervical carcinoma, which is the leading cause of cancer death for women in the US. According to American Society of Clinical Oncology (ASCO), in 2017, an estimated 12,820 women in the U.S. are expected to be diagnosed with cervical cancer along with 4210 deaths every year. Furthermore, ASCO reported 68% increase in survival rate of cervical cancer patients, which suggest increasing use of cervical dysplasia diagnostic and boosting cervical dysplasia diagnostic market to prevent the cervical cancer. Moreover, Europe witnessed high prevalence of cervical cancer. For instance, in 2012, the incidence of cervical cancer in Europe was 58348 individuals per millions, increased by rate of 13.4% whereas mortality was raised by 4.9%. Moreover, government organisation of emerging economies are involved in spreading awareness and conducting screening test for cervical dysplasia, which is expected to drive growth of the cervical dysplasia diagnostic market. Organisations such as National Health Service (NHS) offers cervical screening programmes since 1980s, at the interval of every three year for women of age group 25 to 64 year and every five year above 64 in England, wales and northern Ireland. On the basis of region, cervical dysplasia diagnostic market is segmented into North America, Europe, Asia Pacific, South America, and Middle East. Increasing awareness regarding cervical dysplasia screening programs and technological advancements in screening are the key factors fuelling growth of the North America cervical dysplasia diagnostic market. Moreover, market in Asia Pacific region is expected to witness significant growth over the forecast period, owing to increasing government funding for cervical research and improving healthcare infrastructure. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Cervical Dysplasia Diagnostic Market Research Objective and Assumption • Cervical Dysplasia Diagnostic Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Cervical Dysplasia Diagnostic Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Cervical Dysplasia Diagnostic Market, By Regions • Cervical Dysplasia Diagnostic Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Cervical Dysplasia Diagnostic Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors.

3. • Cervical Dysplasia Diagnostic Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Cervical Dysplasia Diagnostic Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Request For Customization of Research Report @ Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1486 https://www.coherentmarketinsights.com/insight/request-customization/1486 Abbott Laboratories, Qiagen N.V., Hologic Inc., F. Hoffmann La-Roche Ltd., Quest Diagnostics Abbott Laboratories, Qiagen N.V., Hologic Inc., F. Hoffmann La-Roche Ltd., Quest Diagnostics Inc., Becton, Dickinson and Company, Atmos, and Karl Kaps are the major players involved in Inc., Becton, Dickinson and Company, Atmos, and Karl Kaps are the major players involved in cervical dysplasia diagnostic market. cervical dysplasia diagnostic market. Cervical Dysplasia Diagnostic Market Taxonomy: Cervical Dysplasia Diagnostic Market Taxonomy: By Diagnostic By Diagnostic • Diagnostic Test • Pap smear Test • HPV Test • Biopsy Test • Exocervical Biopsy • Endocervical Biopsy • Diagnostic Device • Colposcope By End Users By End Users • Hospitals & Clinics • Diagnostic Centers • Ambulatory Surgical Centers

4. About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com